Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T Cells

Molecular Therapy(2020)10.1016/j.ymthe.2020.05.020Source: DataRank Database

Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T Cells is a research paper published in Molecular Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.99)OA: hybridTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Sudarvili Shanthalingam,Heather L. Sherman,Joe Torres,Barbara A. Osborne ORCID,Gregory N. Tew ORCID

Live enrichment

PubMed:32492367 PMC:PMC7474270 OpenAlex:https://openalex.org/W3027737160

U.S. Department of Defense

Grant: W81XWH1910540

National Institutes of Health

Grant: T GM108556

National Institutes of Health

Grant: 5P01CA16600

NCI NIH HHS

Grant: P01 CA166009

NIGMS NIH HHS

Grant: T32 GM108556

National Institutes of Health

U.S. Department of Defense

FWCI

0.99

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ymthe.2020.05.020

publisherhttps://doi.org/10.1016/j.ymthe.2020.05.020

publisherhttps://api.elsevier.com/content/article/PII:S1525001620302549?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001620302549?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32492367

Fields of Study

CAR-T cell therapy researchT-cell and B-cell ImmunologyImmune Cell Function and Interaction

MeSH Terms

Protein Kinase C-thetaAnimalsAntibodiesCells, CulturedDisease Models, AnimalFemaleGraft vs Host DiseaseHumansImmune ToleranceInterferon-gammaIntracellular FluidSignal TransductionMice, SCIDMice, Inbred NODTreatment OutcomeAdoptive TransferT-Lymphocytes, RegulatoryMiceForkhead Transcription FactorsCell-Penetrating PeptidesProgrammed Cell Death 1 Receptor

Keywords

BiologyCell biologyRegulatory T cellIL-2 receptorImmune systemAntibodyT cellRegulatory B cellsCytotoxic T cellImmunologyB cellIn vitroBiochemistryGraft-versus-host diseaseFOXP3Cell-based TherapyPkcθCell-penetrating Peptide MimicsInduced Regulatory T cellIntracellular Antibody Delivery

Sustainable Development Goals

SDG 0: Good health and well-being

Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T Cells

FAIR Checklist

Authors (7)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)